对治疗结性脊柱炎的阿达利穆马布疗法的概述
Anna M Sukhanova1,2, Mariam A Gilavian1, Elizaveta V Melnik1
1Federal State Autonomous Educational Institution of Higher Education, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, Russia.
Current rheumatology reviews
|February 28, 2024
概括
阿达利马布通过减少疾病活动和改善功能来有效治疗结性脊柱炎 (AS). 这种瘤亡因子 (TNF) 抑制剂具有与安慰剂相比较的良好的安全性,支持其在AS管理中的使用.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 结节性脊柱炎 (AS) 是一种慢性炎症性轴骨疾病,引起疼痛和硬.
- 作为TNF抑制剂的Adalimumab是一种潜在的AS治疗药物.
研究的目的:
- 系统地审查AS治疗的随机对照试验.
- 评估阿达利穆马布在AS治疗中的有效性和安全性.
主要方法:
- 在MEDLINE,Google Scholar和PubMed中对AS治疗RCT进行全面搜索.
- 包括14个RCT与4,500名参与者,专注于阿达利穆马布和其他疗法.
- 分析了与疾病活动,身体功能和炎症标志物相关的结果.
主要成果:
- 在降低AS疾病活性方面,Adalimumab显著优于安慰剂.
- 改善的身体功能和降低的炎症标志物 (CRP,ESR) 被观察到与阿达利木马布.
- 阿达利穆马布表现出良好的安全性,副作用与安慰剂相似.
结论:
- 阿达利穆马布是对AS的有效治疗方法,可能是第一线选择.
- 与安慰剂相比,并没有发现不良事件的显著增加.
- 需要进一步的长期研究来证实阿达利穆马布在AS中的持续有效性和安全性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Alzheimer's Disease: Treatment
188
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
188
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Adrenergic Agonists: Therapeutic Uses
774
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
774


